An ex- Abbott Laboratories Inc. subsidiary sales manager is bound by Minnesota law and doesn’t qualify as an employee to sue ...

Abbott and Flatiron Health recently integrated Abbott's Precision Oncology portfolio into Flatiron's OncoEMR platform, ...

This article examines whether Abbott Laboratories, at around US$104 a share, is starting to look interesting or still pricing ...

Abbott Laboratories (NYSE:ABT) is one of the Best Conservative Stocks to Buy Right Now. On March 23, the company announced that it had completed the acquisition of Exact Sciences. As a result of this, ...

Abbott Laboratories stock reached a 52-week low, hitting a price of 102.39 USD. This milestone underscores a challenging year for the company, as reflected by its 1-year change da ...

The deal brings Exact Sciences' flagship screening test for colorectal cancer, Cologuard, under Abbott's umbrella.

Is ABT a good stock to buy? We came across a bullish thesis on Abbott Laboratories on Compounding Dividends’s Substack by TJ ...

Abbott closes $21B acquisition of Exact Sciences (EXAS) at $105/share. EXAS delisted from Nasdaq on March 23, 2026, becoming ...

Abbott Laboratories will invest $40 million over five years into its highly-scrutinized Michigan plant to resolve stockholder ...

Add Yahoo as a preferred source to see more of our stories on Google. A federal judge handed Abbott Laboratories another win this week in its yearslong battle over the safety of its formulas for ...

North suburban-based Abbott has been entangled in litigation with parents for years over whether its specialized, cow’s milk-based formulas for infants born prematurely cause a life-threatening ...

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S.